Catecholamine-induced polymorphic ventricular tachycardia (CPVT) is a familial disorder caused by cardiac ryanodine receptor type 2 (RyR2) or calsequestrin 2 (CASQ2) gene mutations. To define how CASQ2 mutations cause CPVT, we produced and studied mice carrying a human D307H missense mutation (CASQ307/307) or a CASQ2-null mutation (CASQΔE9/ΔE9). Both CASQ2 mutations caused identical consequences. Young mutant mice had structurally normal hearts but stress-induced ventricular arrhythmias; aging produced cardiac hypertrophy and reduced contractile function. Mutant myocytes had reduced CASQ2 and increased calreticulin and RyR2 (with normal phosphorylated proportions) but unchanged calstabin levels, as well as reduced total sarcoplasmic reticulum (SR) Ca2+, prolonged Ca2+ release, and delayed Ca2+ reuptake. Stress further diminished Ca2+ transients, elevated cytosolic Ca2+, and triggered frequent, spontaneous SR Ca2+ release. Treatment with Mg2+, a RyR2 inhibitor, normalized myocyte Ca2+ cycling and decreased CPVT in mutant mice, indicating RyR2 dysfunction was critical to mutant CASQ2 pathophysiology. We conclude that CPVT-causing CASQ2 missense mutations function as null alleles. In the absence of CASQ2, calreticulin, a fetal Ca2+-binding protein normally downregulated at birth, remains a prominent SR component. Adaptive changes to CASQ2 deficiency (increased posttranscriptional expression of calreticulin and RyR2) maintained electrical-mechanical coupling, but increased RyR2 leakiness, a paradoxical response further exacerbated by stress. The central role of RyR2 dysfunction in CASQ2 deficiency unifies the pathophysiologic mechanism underlying CPVT due to RyR2 or CASQ2 mutations and suggests a therapeutic approach for these inherited cardiac arrhythmias.
Lei Song, Ronny Alcalai, Michael Arad, Cordula M. Wolf, Okan Toka, David A. Conner, Charles I. Berul, Michael Eldar, Christine E. Seidman, J.G. Seidman
Title and authors | Publication | Year |
---|---|---|
From Genome-Wide Association Studies to Cardiac Electrophysiology: Through the Maze of Biological Complexity
KT Scholman, VM Meijborg, C Gálvez-Montón, EM Lodder, BJ Boukens |
Frontiers in physiology | 2020 |
Calcium Handling Defects and Cardiac Arrhythmia Syndromes
K Kistamás, R Veress, B Horváth, T Bányász, PP Nánási, DA Eisner |
Frontiers in pharmacology | 2020 |
Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants
G Valle, M Arad, P Volpe |
Journal of Muscle Research and Cell Motility | 2020 |
Buffering and total calcium levels determine the presence of oscillatory regimes in cardiac cells
M Marchena, B Echebarria, Y Shiferaw, E Alvarez-Lacalle, AD McCulloch |
PLoS computational biology | 2020 |
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia
K Ng, EW Titus, KV Lieve, TM Roston, A Mazzanti, FH Deiter, I Denjoy, J Ingles, J Till, T Robyns, SP Connors, C Steinberg, DJ Abrams, B Pang, MM Scheinman, JM Bos, SA Duffett, C van der Werf, A Maltret, MS Green, J Rutberg, S Balaji, J Cadrin-Tourigny, KM Orland, LM Knight, C Brateng, J Wu, AS Tang, AC Skanes, J Manlucu, JS Healey, CT January, AD Krahn, KK Collins, KR Maginot, P Fischbach, SP Etheridge, LL Eckhardt, RM Hamilton, MJ Ackerman, FR Noguer, C Semsarian, N Jura, A Leenhardt, MH Gollob, SG Priori, S Sanatani, AA Wilde, RC Deo, JD Roberts |
Circulation | 2020 |
Integrin β1D Deficiency-Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in ARVC
Y Wang, C Li, L Shi, X Chen, C Cui, J Huang, B Chen, DD Hall, Z Pan, M Lu, J Hong, LS Song, S Zhao |
Circulation | 2020 |
Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse
M Cacheux, J Fauconnier, J Thireau, A Osseni, J Brocard, N Roux-Buisson, J Brocard, J Fauré, A Lacampagne, I Marty |
Molecular Therapy | 2020 |
The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia
H Bueno-Levy, D Weisbrod, D Yadin, S Haron-Khun, A Peretz, E Hochhauser, M Arad, B Attali |
Frontiers in pharmacology | 2020 |
Phylogenetic and biochemical analysis of calsequestrin structure and association of its variants with cardiac disorders
Q Wang, T Paskevicius, A Filbert, W Qin, HJ Kim, XZ Chen, J Tang, JB Dacks, LB Agellon, M Michalak |
Scientific Reports | 2020 |